General Introductions, appropriations
Source-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- May 21, 2026
- Income
- $7,500.00
- Expenses
- Not reported
- Registrant
- TERRAPIN STRATEGY, INC
- Client
- SANA HEALTH
- Filing UUID
- 72d5cd6e-bf4a-408f-9573-2fa9752ac9bb
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
General Introductions
S 4220 The Novel Therapeutics Act and education on PTSD therapies
Literal federal measure citations: S 4220
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.